<VariationArchive VariationID="847449" VariationName="NM_182760.4(SUMF1):c.339dup (p.Ala114fs)" VariationType="Duplication" Accession="VCV000847449" Version="4" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="828181" VariationID="847449">
      <GeneList>
        <Gene Symbol="SUMF1" FullName="sulfatase modifying factor 1" GeneID="285362" HGNC_ID="HGNC:20376" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>3p26.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="4034486" stop="4467269" display_start="4034486" display_stop="4467269" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="4402828" stop="4508965" display_start="4402828" display_stop="4508965" Strand="-" />
          </Location>
          <OMIM>607939</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_182760.4(SUMF1):c.339dup (p.Ala114fs)</Name>
      <CanonicalSPDI>NC_000003.12:4452980:TT:TTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>3p26.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="3" Accession="NC_000003.12" start="4452980" stop="4452981" display_start="4452980" display_stop="4452981" variantLength="1" positionVCF="4452980" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="3" Accession="NC_000003.11" start="4494664" stop="4494665" display_start="4494664" display_stop="4494665" variantLength="1" positionVCF="4494664" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>A114fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.11" sequenceAccession="NC_000003" sequenceVersion="11" change="g.4494666dup" Assembly="GRCh37">
            <Expression>NC_000003.11:g.4494666dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000003.12" sequenceAccession="NC_000003" sequenceVersion="12" change="g.4452982dup" Assembly="GRCh38">
            <Expression>NC_000003.12:g.4452982dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016225.2" sequenceAccession="NG_016225" sequenceVersion="2" change="g.19302dup">
            <Expression>NG_016225.2:g.19302dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164674.2" sequenceAccession="NM_001164674" sequenceVersion="2" change="c.339dup">
            <Expression>NM_001164674.2:c.339dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001158146.1" sequenceAccession="NP_001158146" sequenceVersion="1" change="p.Ala114fs">
            <Expression>NP_001158146.1:p.Ala114fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001164675.2" sequenceAccession="NM_001164675" sequenceVersion="2" change="c.339dup">
            <Expression>NM_001164675.2:c.339dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001158147.1" sequenceAccession="NP_001158147" sequenceVersion="1" change="p.Ala114fs">
            <Expression>NP_001158147.1:p.Ala114fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_182760.4" sequenceAccession="NM_182760" sequenceVersion="4" change="c.339dup" MANESelect="true">
            <Expression>NM_182760.4:c.339dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_877437.2" sequenceAccession="NP_877437" sequenceVersion="2" change="p.Ala114fs">
            <Expression>NP_877437.2:p.Ala114fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1703025184" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_182760.4(SUMF1):c.339dup (p.Ala114fs) AND Multiple sulfatase deficiency" Accession="RCV001050991" Version="4">
        <ClassifiedConditionList TraitSetID="683">
          <ClassifiedCondition DB="MedGen" ID="C0268263">Multiple sulfatase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-03" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-03" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12757705</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12757706</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25885655</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="683" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5566" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Multiple sulfatase deficiency</ElementValue>
                <XRef ID="Multiple+sulfatase+deficiency/4972" DB="Genetic Alliance" />
                <XRef ID="54898003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Juvenile sulfatidosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mucosulfatidosis</ElementValue>
                <XRef ID="MONDO:0010088" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Sulfatidosis, Juvenile, Austin Type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Multiple Sulfatase Deficiency Disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MSD</ElementValue>
                <XRef Type="MIM" ID="272200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5061" />
                <XRef ID="5061" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Initial symptoms of multiple sulfatase deficiency (MSD) can develop from infancy through early childhood, and presentation is widely variable. Some individuals display the multisystemic features characteristic of mucopolysaccharidosis disorders (e.g., developmental regression, organomegaly, skeletal deformities) while other individuals present primarily with neurologic regression (associated with leukodystrophy). Based on age of onset, rate of progression, and disease severity, several different clinical subtypes of MSD have been described: Neonatal MSD is the most severe with presentation in the prenatal period or at birth with rapid progression and death occurring within the first two years of life. Infantile MSD is the most common variant and may be characterized as attenuated (slower clinical course with cognitive disability and neurodegeneration identified in the 2nd year of life) or severe (loss of the majority of developmental milestones by age 5 years). Juvenile MSD is the rarest subtype with later onset of symptoms and subacute clinical presentation. Many of the features found in MSD are progressive, including neurologic deterioration, heart disease, hearing loss, and airway compromise.</Attribute>
                <XRef ID="NBK538937" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">30896912</ID>
                <ID Source="BookShelf">NBK538937</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/MPS-II.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Iduronate 2-Sulfatase Deficiency, Mucopolysaccharidosis Type II, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/MPS-II-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Mucopolysacchardosis Type II (MPSII): Decreased Iduronate 2-Sulfatase (I2S) activity, 2022</CitationText>
              </Citation>
              <XRef ID="585" DB="Orphanet" />
              <XRef ID="C0268263" DB="MedGen" />
              <XRef ID="MONDO:0010088" DB="MONDO" />
              <XRef Type="MIM" ID="272200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2380511" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="8195004|MedGen:C0268263" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001215124" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12757705</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12757706</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25885655</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 847449). This variant has not been reported in the literature in individuals affected with SUMF1-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ala114Serfs*9) in the SUMF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SUMF1 are known to be pathogenic (PMID: 12757705, 12757706, 25885655).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SUMF1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000003.11:g.4494664_4494665insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268263" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2380511" TraitType="Disease" MappingType="XRef" MappingValue="C0268263" MappingRef="MedGen">
        <MedGen CUI="C0268263" Name="Multiple sulfatase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

